114 related articles for article (PubMed ID: 2419700)
1. Protection by the calcium antagonist tiapamil, against cardiac lymphatic enzyme leakage and arrhythmias in canine hearts during reperfusion.
Matsuura A; Ishihara T; Nakamura K; Himori N; Nakamura K
J Cardiovasc Pharmacol; 1986; 8(1):90-8. PubMed ID: 2419700
[TBL] [Abstract][Full Text] [Related]
2. Effect of tiapamil on canine myocardial infarct size.
Kordenat K; Leasure J
Am Heart J; 1986 Mar; 111(3):502-12. PubMed ID: 3953359
[TBL] [Abstract][Full Text] [Related]
3. Effect of tiapamil and nifedepine during critical coronary stenosis and in the presence of adrenergic beta-receptor blockade in anesthetized dogs.
Saini RK; Fulmor IE; Antonaccio MJ
J Cardiovasc Pharmacol; 1982; 4(5):770-6. PubMed ID: 6182408
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of tiapamil against ventricular fibrillation during coronary artery occlusion.
Raeder EA; Verrier RL; Lown B
Am Heart J; 1986 May; 111(5):878-82. PubMed ID: 3706107
[TBL] [Abstract][Full Text] [Related]
5. Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog.
Vogel WM; Zannoni VG; Abrams GD; Lucchesi BR
Circulation; 1977 Apr; 55(4):588-95. PubMed ID: 837501
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic and haemodynamic effects of tiapamil, a new calcium antagonist, during coronary artery occlusion and reperfusion in dogs.
Shargorodsky BM; Braun S; Belhassen B; Laniado S
Cardiovasc Res; 1986 Sep; 20(9):652-7. PubMed ID: 3791354
[TBL] [Abstract][Full Text] [Related]
7. Effects of tiapamil on haemodynamics and myocardial salvage during myocardial infarction in the baboon.
Rogers GG; Rosendorff C; Shimell CJ; Coull A
Cardiology; 1982; 69 Suppl():58-67. PubMed ID: 7151084
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic effects of tiapamil on exercise-induced arrhythmias in patients with coronary artery disease.
Burkart F; Baitsch G; Braun S; Bertel O; Cocco G
Cardiology; 1982; 69 Suppl():165-71. PubMed ID: 6758932
[TBL] [Abstract][Full Text] [Related]
9. Tiapamil--a new calcium antagonist.
Opie LH; Muller CA; Thandroyen FT; Lloyd EA; Mabin T; Commerford PJ; Eichler HG
S Afr Med J; 1985 Jun; 67(22):881-3. PubMed ID: 3890216
[TBL] [Abstract][Full Text] [Related]
10. Effects of tiapamil on myocardial performance in coronary artery disease.
Braun S; Miller H; Terdiman R; Laniado S
Cardiology; 1982; 69 Suppl():79-84. PubMed ID: 7151086
[TBL] [Abstract][Full Text] [Related]
11. Parenteral tiapamil treatment of arrhythmias in cardiac patients.
Menzel T; Kirchner P
Cardiology; 1982; 69 Suppl():192-8. PubMed ID: 6185224
[TBL] [Abstract][Full Text] [Related]
12. [Management of supraventricular and ventricular arrhythmias with the intravenous administration of the calcium antagonist Tiapamil (Ro 11-1781) (author's transl)].
Menzel T; Kirchner P; Cocco G; Gasser DF
Z Kardiol; 1981 Mar; 70(3):163-71. PubMed ID: 6165153
[TBL] [Abstract][Full Text] [Related]
13. Tiapamil in the treatment of lidocaine-resistant ventricular arrhythmias complicating acute myocardial infarction.
Lessem J
Cardiology; 1982; 69 Suppl():199-208. PubMed ID: 7151080
[TBL] [Abstract][Full Text] [Related]
14. Verapamil and tiapamil in prevention of ventricular fibrillation in pigs with coronary ligation. Comparative effects on left ventricular function.
Muller CA; Opie LH; Hamm CW; Peisach M; Pineda CA; Thandroyen FT
Circulation; 1988 Jul; 78(1):227-32. PubMed ID: 3383406
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of tiapamil (Ro 11-1781), a new calcium-entry blocker.
Gerold M; Eigenmann R; Haeusler G
J Cardiovasc Pharmacol; 1982; 4(3):419-29. PubMed ID: 6177938
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic effect of the calcium antagonist tiapamil (Ro 11-1781) by intravenous administration in patients with coronary heart disease.
Nowak FG; Cocco G; Chu D; Gasser DF
Clin Cardiol; 1980 Dec; 3(6):371-6. PubMed ID: 6161729
[TBL] [Abstract][Full Text] [Related]
17. Effects of KR-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarction and arrhythmias induced by ischemia and reperfusion.
Lee BH; Yi KY; Lee S; Lee S; Yoo SE
Eur J Pharmacol; 2005 Oct; 523(1-3):101-8. PubMed ID: 16226744
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic effect of tiapamil in patients with acute myocardial infarction.
Dubner S; Gimeno G; Elencwajg B; Quinteiro R; Tronge J; Bertolasi C
Cardiology; 1982; 69 Suppl():172-80. PubMed ID: 7151078
[TBL] [Abstract][Full Text] [Related]
19. Effect of reperfusion on myocardial infarct, and the accuracy of estimating infarct size from serum creatine phosphokinase in the dog.
Jarmakani JM; Limbird L; Graham TC; Marks RA
Cardiovasc Res; 1976 Mar; 10(2):245-53. PubMed ID: 938992
[TBL] [Abstract][Full Text] [Related]
20. Tiapamil, a new calcium antagonist: hemodynamic effects in patients with acute myocardial infarction.
Eichler HG; Mabin TA; Commerford PJ; Lloyd EA; Beck W; Opie LH
Circulation; 1985 Apr; 71(4):779-86. PubMed ID: 3882269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
